Browse all articles >
Ursolic acid targets secreted phosphoprotein 1 to regulate Th17 cells against non-alcoholic fatty liver disease
Global incidence of adverse clinical events in non-alcoholic fatty liver disease: A systematic review and meta-analysis2024 April;30(2)
Recent updates on pharmacologic therapy in non-alcoholic fatty liver disease2024 January;30(1)
Correspondence on Letter regarding “Risk factors in nonalcoholic fatty liver disease”2023 October;29(4)
Letter regarding “Risk factors in nonalcoholic fatty liver disease”2023 October;29(4)